As Nueterra Capital CEO, Jeremy oversees all firm-wide operations, provides leadership, and is responsible for setting the strategic direction of the company. Jeremy joined Nueterra Capital in 2001 as one of the company’s first investment executives, focused on investments in the healthcare provider sector. Prior to that, he was CEO of Astoria Healthcare Properties, which focuses on real estate investments and development. Jeremy currently serves on the Investment Committees for Nueterra Capital, Grayson Capital, and Open Prairie Ventures and serves on the board for HealthJoy. Jeremy led previous deals in Casetabs (acquired by HST Pathways) and Triggr Health (acquired by SonarMD).
